1 / 12

AVAILABILITY OF DRUGS: WHAT DOES IT MEAN IN UGANDAN PRIMARY CARE?

AVAILABILITY OF DRUGS: WHAT DOES IT MEAN IN UGANDAN PRIMARY CARE?. Jessica Jitta, S. R Whyte, N. Nshakira Child Health Development Center Makerere University Uganda & Institute of Anthropology University Copenhagen Denmark. ABSTRACT. Presentation covers areas below:

thanh
Télécharger la présentation

AVAILABILITY OF DRUGS: WHAT DOES IT MEAN IN UGANDAN PRIMARY CARE?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AVAILABILITY OF DRUGS: WHAT DOES IT MEAN IN UGANDAN PRIMARY CARE? Jessica Jitta, S. R Whyte, N. Nshakira Child Health Development Center Makerere University Uganda & Institute of Anthropology University Copenhagen Denmark

  2. ABSTRACT Presentation covers areas below: • Introduction/background • Objectives • Methods • Findings • Conclusions

  3. INTRODUCTION • Uganda public- 40%, PNFP 25% and PP 35% • Health reforms Ugandan HS initiated 1990s as central efforts to rebuild the health system • Reforms assume rational drug management ensures drug availability &quality care • Tension assumption- reality HWs responsive to users’ demands& being rational drug manager • Introduction user fees -health as commodity and users demanding value for money

  4. OBJECTIVES • To examine drug availability at primary health care level, with a focus on the inconsistencies in drug supply policy and the gap between policy and practice.

  5. METHODOLOGY • Cross-sectional qualitative and quantitative KI, FGD,observe consultations and records review • 6 units- a public rural hospital OPD, 3 HCs, a sub-dispensary and an church NGO dispensary • Policy makers/administrators (KI 67); users (54FGD)observed consult(140) exit interviews (160) entries patient registers (600) • Analysis -significance drug availability HCW, users and planners/administrators -realities that HCWs and their patients face -district context national policy • Supply, utilization and expectations/demand for inj chloroq, penicillin & availability of needles/syringes.

  6. FINDINGS- Sources of drugs • Public units- EDMP pre-packed kits quarterly to districts , district buy suppl drugs, special vertical programs (TB, STD) & h/units procure drugs &needles and syringes • Patients referred to drugshops buy drugs- 40% • NGO depend only procuring drugs-not limited • Planners concerned EDMP, no policy on drug supplements by units • To users most important- obtain needed drugs

  7. FINDINGS- Types drugs available • Volume and range services at unit determine EDMP kits supplied and National Standard Guide available for rational drug use • Most used drugs anti-malaria, antibiotics and analgesics • Inj medicines on high demand, went o/s first • Units put user fees to supplement stocks to overcome chronic o/s & increase range of drugs, needles & syringes and IV fluids • Health unit records on supplements poor

  8. FINDINGS- Diagnosis & prescript • Varied with cadre and number of h/providers- skills vary with level health units • Symptomatic diagnosis lack of support facilities • Very sick patients (children vomiting) injections prescribed • High rate use of combination antibiotics and anti-malaria- many drugs (poly-pharmacy) • Very high injection rates 35-85% compared to recommended 15%-providers respond users demands- previous oral form taken no response

  9. FINDINGS- Drug suff/adequacy • New kits open only exhausting contents • Drugs used at different rates • Injection drugs run out first unit supp • 40% exit interviews referred drug shop • Planners/admin EDMP adequate in units • Providers unsatisfied injection drugs antibiotics and anti-malaria • Users concerns drug availability at unit,get injections, affordable and adequate dosage

  10. FINDINGS- Availability issues • Health sector reforms have changed the conditions for managing, supplying and using drugs through decentralization, user fees and privatization. • Injection drugs in kits ran out quickly and were purchased by the unit or the patient at nearby drug shops. • Government health units both compete with & use local commercial sources of drugs undermining technical premise rational drug use and supply built into kit system.

  11. FINDINGS- Quality care perspt • Drugs availability is fundamental quality of care by all 3 categories of actors PHC, perspective differ& shifting • Plan/admin- securing suppl EDMP kits-delivery, records account/stocktaking, mism’gment/leakages at HU-control & security of drugs-manuals&guidelines rational use drug • H/workers not relate insuff to drug to diagnosis prescription but-inadequate supplies in kits, large numbers infectious diseases and need to satisfy pts with injections- purchase suppl drugs, refer pts buy p/shops • Users- in terms whether all prescribed drugs are good obtainable at HU regardless source, inj preferred form

  12. CONCLUSIONS • Problem of drug availability interlinked, so is perspectives and interests of actors • Dialogue and realism are needed in order to create policies that respect both good medical treatment standards and the concerns of frontline health workers and their patients. • Rethinking of the meaning of drug availability in PHC calls for methodologies examining the changing context of h/care & position of diff actors, at national and district levels, to address gaps existing between drug policy and practice

More Related